Researchers at the University of Bayreuth have, for the first time, deciphered key steps in the biosynthetic mechanism of the ...

Computational pathology-informed immune biomarker for trastuzumab benefit in HER2+ breast cancer: Validation in NSABP B-41 clinical trial. Analysis of event-free survival (EFS) of stromal tumor ...

—In this study, molecular classification of endometrial cancer with cervical stromal invasion was associated with recurrence-free survival by univariate analysis. But after controlling for tumor stage ...

What if clinicians could predict the success of any cancer treatment, ensuring each patient receives the most effective care? The challenge lies in the diverse nature of the disease. There are ...